Archive Newsletter

31. 04.30.25 -- Ramping Up GMP-Compliant CAR-NK Manufacturing At Scale With iPSCs 4/30/2025
    04/30/25 Cell & Gene Newsletter
32. 04.29.25 -- STREAM Edition: How The FDA Strengthens Industry Collaboration 4/29/2025
    04/29/25 Cell & Gene Newsletter
33. 04.29.25 -- The Cell And Gene Therapy Dilemma: Centralized Vs. Decentralized Manufacturing 4/29/2025
    04/29/25 Cell & Gene Newsletter
34. 04.28.25 -- Vial Containment Systems For Gene Therapies 4/28/2025

    04/28/25 Cell & Gene Newsletter

35. 04.28.25 -- Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers 4/28/2025
    04/28/25 Cell & Gene Newsletter
36. 04.25.25 -- Why You Need A Raw Material Control Strategy 4/25/2025
    04/25/25 Cell & Gene Newsletter
37. 04.24.25 -- Clinical Data Like You've Never Seen it Before 4/24/2025

    04/24/25 Cell & Gene Newsletter

38. 04.24.25 -- How Cynata Therapeutics Is Unlocking The Power Of iPSCs To Transform Regenerative Medicine 4/24/2025
    04/24/25 Cell & Gene Newsletter
39. 04.23.25 -- Enhancing Precision & Efficiency In Gene Editing Research 4/23/2025

    04/23/25 Cell & Gene Newsletter

40. 04.23.25 -- Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials 4/23/2025
    04/23/25 Cell & Gene Newsletter